Alexander A Fitzpatrick Silverback Therapeutics, Inc. (SBTX) insider trading activity

Alexander A Fitzpatrick is Chief Legal Officer of Silverback Therapeutics, Inc.. Currently has a direct ownership of 89,613 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on May 20, 2025, when has been sold 102,969 shares (Common Stock) at a price of $14.1 per share, resulting in proceeds of $1,451,862. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 89.6K

0.43% 3M change

0.43% 12M change

Total Value Held $0

Alexander A Fitzpatrick Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2025	SELL Open market or private sale	$1,451,862 $14.1 p/Share	102,969 Reduced 53.47%	89,613 Common Stock
May 20 2025	BUY Exercise of conversion of derivative security	$558,000 $5.58 p/Share	100,000 Added 34.18%	192,582 Common Stock
Sep 29 2023	BUY Open market or private purchase	$174,855 $3.78 p/Share	46,258 Added 34.14%	89,227 Common Stock
Sep 28 2023	BUY Open market or private purchase	$144,800 $3.62 p/Share	40,000 Added 48.21%	42,969 Common Stock

Also insider at

EVFM

Evofem Biosciences, Inc. Healthcare

General Counsel and Secretary

AAF